{"name": "AkaRx",
 "permalink": "akarx",
 "crunchbase_url": "http://www.crunchbase.com/company/akarx",
 "homepage_url": "",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2005,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "201-909-3000",
 "description": "",
 "created_at": "Fri Jan 08 10:32:43 UTC 2010",
 "updated_at": "Wed Jan 13 12:42:06 UTC 2010",
 "overview": "\u003Cp\u003EAkaRx, Inc., a biopharmaceutical company, develops therapeutic treatments for unmet medical needs. Its product includes AKR-501, an orally-available small molecule for use in the treatment of thrombocytopenia. The company was founded in 2005 and is headquartered in Paramus, New Jersey.\u003C/p\u003E",
 "image": null,
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Co-Founder ",
    "person":
     {"first_name": "Robert",
      "last_name": "E. Desjardins",
      "permalink": "robert-e-desjardins",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$26.1M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29\u0026aid=DJFVLS0020100108e61800030\u0026r=Rss\u0026s=DJFVLS",
    "source_description": " Eisai's $255M AkaRx Buy Creates Returns For InterWest, Sutter Hill",
    "raised_amount": 26100000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 1,
    "funded_day": 7,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "InterWest Partners",
         "permalink": "interwest-partners",
         "image":
          {"available_sizes":
            [[[117,
               56],
              "assets/images/resized/0002/9316/29316v1-max-150x150.png"],
             [[117,
               56],
              "assets/images/resized/0002/9316/29316v1-max-250x250.png"],
             [[117,
               56],
              "assets/images/resized/0002/9316/29316v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Sutter Hill Ventures",
         "permalink": "sutter-hill-ventures",
         "image":
          {"available_sizes":
            [[[150,
               14],
              "assets/images/resized/0003/0838/30838v1-max-150x150.png"],
             [[250,
               23],
              "assets/images/resized/0003/0838/30838v1-max-250x250.png"],
             [[432,
               41],
              "assets/images/resized/0003/0838/30838v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition":
  {"price_amount": 255000000.0,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "http://www.eisai.co.jp/enews/enews201001.html",
   "source_description": "Eisai Completes Acquisition of AkaRx, Inc. in the United States",
   "acquired_year": 2010,
   "acquired_month": 1,
   "acquired_day": 7,
   "acquiring_company":
    {"name": "Eisai",
     "permalink": "eisai-co",
     "image":
      {"available_sizes":
        [[[150,
           38],
          "assets/images/resized/0007/3196/73196v1-max-150x150.jpg"],
         [[187,
           48],
          "assets/images/resized/0007/3196/73196v1-max-250x250.jpg"],
         [[187,
           48],
          "assets/images/resized/0007/3196/73196v1-max-450x450.jpg"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Mack Centre IV",
    "address2": "4th Floor",
    "zip_code": "07652",
    "city": "Paramus",
    "state_code": "NJ",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}